Advances in the treatment of blood disorders.
D000741:Anemia, Aplastic / Q000188:drug therapy; D000743:Anemia, Hemolytic / Q000188:drug therapy; D000745:Anemia, Hemolytic, Congenital / Q000517:prevention & control; D000747:Anemia, Hypochromic / Q000188:drug therapy; D000752:Anemia, Pernicious / Q000188:drug therapy; D000925:Anticoagulants / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use; D004899:Erythroblastosis, Fetal / Q000628:therapy; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005342:Fibrinolysis; D005494:Folic Acid Deficiency / Q000188:drug therapy; D006402:Hematologic Diseases / Q000628:therapy*; D006453:Hemoglobinopathies / Q000628:therapy; D006467:Hemophilia A / Q000628:therapy; D002836:Hemophilia B / Q000628:therapy; D006801:Humans; D007231:Infant, Newborn; D007501:Iron / Q000627:therapeutic use; D007938:Leukemia / Q000188:drug therapy / Q000532:radiotherapy; D011247:Pregnancy; D013156:Splenectomy; D014805:Vitamin B 12 / Q000627:therapeutic use; D014806:Vitamin B 12 Deficiency; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy
D000925:Anticoagulants; D002614:Chelating Agents; D007501:Iron; D014805:Vitamin B 12